Broadcast Date: 
  • Time: 

Join the science writing talent from Genetic Engineering & Biotechnology News in a live fireside chat on the latest science and business news in the COVID-19 pandemic.

Since the COVID-19 outbreak began, GEN has been diligently covering the research and medical advances that are helping us better understand, diagnose and defeat the novel coronavirus. In this debut “GEN Live” fireside chat, GEN science editors Julianna LeMieux and Alex Philippidis will discuss the latest medical advances in drug and vaccine development, as well as diagnostic and antibody testing. They’ll go beyond the written word to share news and insights, ranking the frontrunner drug and vaccine candidates aiming to vanquish the virus.

Attendees were able to ask questions live or via chat/social media.

• Julianna LeMieux – GEN Senior Science Writer
• Alex Philippidis – GEN Senior Business Writer

Moderated by: Kevin Davies select GEN/The CRISPR Journal)

Produced with support from:

synthego logo
Alex Philippidis

Alex Philippidis
GEN Senior Business Writer

Julianna LeMieux

Julianna LeMieux, PhD
GEN Senior Science Writer